New drug cocktail aims to boost breast cancer treatment
Disease control
Recruiting now
This early-phase trial tests whether adding dupilumab (an allergy drug) to standard chemotherapy and immunotherapy is safe for people with locally advanced triple-negative breast cancer. About 15 participants will receive the combination before surgery. The main goal is to check …
Phase: EARLY_PHASE1 • Sponsor: Rima Patel • Aim: Disease control
Last updated May 16, 2026 18:53 UTC